MR Solutions is a developer of innovative preclinical imaging solutions. The company’s superconducting, cryogen-free, preclinical MRI systems up to 7 Tesla are suitable for in vivo investigations in areas such as oncology, developmental biology, cardiovascular disease, neurology and drug development. They are complemented by multimodality capabilities with imaging modalities, such as PET and SPECT for real-time/simultaneous imaging with MRI.
The systems feature the company’s cryogen-free superconducting magnet technology, which eliminates the need for liquid helium cooling. The MRIs are self-shielded, which means room shielding is not required. The lack of liquid helium means installation requirements such as quench pipes are not required.
The MRIs have small fringe-fields and can be operated next to other sensitive laboratory systems. This means multimodality imaging is easily achieved. The systems come with field strengths from 3 to 7 T and bore sizes from 17 to 31 cm, making them suited to all small animal models.
PET and SPECT modules expand the MRI system with multimodal imaging capabilities, with the different data sets able to be simultaneously acquired. It is possible to operate the same MRI at different field strengths, further enhancing the capabilities of the instruments.
Phone: 02 9450 1359
Refeyn MassFluidix HC upgraded microfluidic system
Refeyn has introduced a next-generation microfluidic chip and other improvements to its...
MBF Bioscience SLICE high-performance light sheet microscope
The SLICE light sheet microscope, by MBF Bioscience, combines high performance with a compact...
Yokogawa CellVoyager High-Content Analysis System CQ3000
The CellVoyager High-Content Analysis System CQ3000, by Yokogawa, can acquire high-resolution 3D...